Actively Recruiting
International Headache and Vertigo Registration Study
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2025-05-23
200000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
S
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor
Z
Zhejiang University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying patients aged 4 to 99 years who experience various types of headaches, vertigo conditions, and chronic pain, including migraine, tension-type headache, vestibular migraine, and fibromyalgia. This international registration study aims to investigate biomarkers, imaging features, heart-lung shunts, genetic characteristics, treatments, and outcomes related to these headache-related disorders with planned long-term follow-up. Participants are grouped by headache and vertigo types, including migraine (all types), other primary headache disorders, vertigo disorders excluding vestibular migraine, secondary headache disorders, and a group of normal individuals without headache or vertigo. The study collects detailed clinical data and assessments, focusing on real-world treatment and disease characteristics. Participants will undergo evaluations including symptom diaries, biomarker tests, various MRI imaging methods, echocardiography, and questionnaires measuring headache impact, disability, quality of life, mental health, and physical function. The study tracks outcomes such as migraine and headache days, attack frequency, pain intensity, and physiological measures over medium and long-term periods, with continuous monitoring planned for up to 60 years.
CONDITIONS
Brief Title
International Headache Registry Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provide written informed consent and privacy authorization before any study procedures
- Male or female participants aged 4 to 99 years at the first visit
- Diagnosed with primary or secondary headaches per ICHD-3 criteria, including migraine, tension-type headache, vestibular migraine, or other headache disorders in the ICHD-3 appendix
You will not qualify if you...
- Unable to complete headache diaries or related scales
- Declined or unable to participate in long-term follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 6 months after initial diagnosis
Participants undergo assessments including biomarkers, imaging, heart shunt evaluations, and genetic studies related to headache and vertigo conditions.
1 to 2 visits depending on diagnostic procedures
Duration - Up to 60 years
Participants are followed over long-term periods to monitor outcomes such as migraine days, headache intensity, and quality of life measures.
Periodic follow-up visits as scheduled during the study
Trial Site Locations
Total: 1 location
1
Kaiming Liu
Hangzhou, Zhejiang, China, 370001
Actively Recruiting
Research Team
K
Kaiming Liu, Doctor
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here